nodes	percent_of_prediction	percent_of_DWPC	metapath
Aprepitant—colon cancer—Dexamethasone—allergic rhinitis	0.2	0.366	CpDpCtD
Aprepitant—colon cancer—Betamethasone—allergic rhinitis	0.2	0.366	CpDpCtD
Aprepitant—breast cancer—Betamethasone—allergic rhinitis	0.0734	0.134	CpDpCtD
Aprepitant—breast cancer—Dexamethasone—allergic rhinitis	0.0734	0.134	CpDpCtD
Aprepitant—CYP2C19—Desloratadine—allergic rhinitis	0.0273	0.09	CbGbCtD
Aprepitant—CYP1A2—Desloratadine—allergic rhinitis	0.0252	0.0831	CbGbCtD
Aprepitant—CYP2C9—Desloratadine—allergic rhinitis	0.0227	0.0749	CbGbCtD
Aprepitant—CYP2C19—Loratadine—allergic rhinitis	0.0157	0.0517	CbGbCtD
Aprepitant—CYP2C19—Diphenhydramine—allergic rhinitis	0.0157	0.0517	CbGbCtD
Aprepitant—CYP1A2—Diphenhydramine—allergic rhinitis	0.0145	0.0477	CbGbCtD
Aprepitant—CYP3A7—Hydrocortisone—allergic rhinitis	0.0144	0.0475	CbGbCtD
Aprepitant—CYP3A7-CYP3A51P—Hydrocortisone—allergic rhinitis	0.0144	0.0475	CbGbCtD
Aprepitant—CYP3A4—Flunisolide—allergic rhinitis	0.0132	0.0435	CbGbCtD
Aprepitant—CYP2C9—Montelukast—allergic rhinitis	0.0131	0.043	CbGbCtD
Aprepitant—CYP2C9—Loratadine—allergic rhinitis	0.0131	0.043	CbGbCtD
Aprepitant—CYP2C9—Diphenhydramine—allergic rhinitis	0.0131	0.043	CbGbCtD
Aprepitant—CYP3A4—Olopatadine—allergic rhinitis	0.0124	0.0409	CbGbCtD
Aprepitant—TACR3—Tachykinin receptors bind tachykinins—TAC1—allergic rhinitis	0.0113	0.319	CbGpPWpGaD
Aprepitant—CYP3A5—Hydrocortisone—allergic rhinitis	0.0108	0.0357	CbGbCtD
Aprepitant—CYP3A7-CYP3A51P—Dexamethasone—allergic rhinitis	0.00898	0.0296	CbGbCtD
Aprepitant—CYP3A7—Dexamethasone—allergic rhinitis	0.00898	0.0296	CbGbCtD
Aprepitant—CYP3A4—Montelukast—allergic rhinitis	0.00759	0.025	CbGbCtD
Aprepitant—CYP3A4—Loratadine—allergic rhinitis	0.00759	0.025	CbGbCtD
Aprepitant—CYP3A4—Methylprednisolone—allergic rhinitis	0.00694	0.0229	CbGbCtD
Aprepitant—CYP3A5—Dexamethasone—allergic rhinitis	0.00673	0.0222	CbGbCtD
Aprepitant—TACR1—Tachykinin receptors bind tachykinins—TAC1—allergic rhinitis	0.00551	0.156	CbGpPWpGaD
Aprepitant—CYP2C19—Dexamethasone—allergic rhinitis	0.00543	0.0179	CbGbCtD
Aprepitant—CYP3A4—Triamcinolone—allergic rhinitis	0.00526	0.0173	CbGbCtD
Aprepitant—CYP2C9—Dexamethasone—allergic rhinitis	0.00452	0.0149	CbGbCtD
Aprepitant—CYP3A4—Betamethasone—allergic rhinitis	0.00451	0.0149	CbGbCtD
Aprepitant—CYP3A4—Prednisolone—allergic rhinitis	0.00445	0.0147	CbGbCtD
Aprepitant—CYP3A4—Hydrocortisone—allergic rhinitis	0.00422	0.0139	CbGbCtD
Aprepitant—CYP3A4—Dexamethasone—allergic rhinitis	0.00263	0.00865	CbGbCtD
Aprepitant—TACR3—G alpha (q) signalling events—CYSLTR1—allergic rhinitis	0.000887	0.0251	CbGpPWpGaD
Aprepitant—TACR3—Peptide ligand-binding receptors—CCL11—allergic rhinitis	0.000846	0.0239	CbGpPWpGaD
Aprepitant—TACR3—Gastrin-CREB signalling pathway via PKC and MAPK—CYSLTR1—allergic rhinitis	0.000794	0.0225	CbGpPWpGaD
Aprepitant—TACR3—Class A/1 (Rhodopsin-like receptors)—PTGDR2—allergic rhinitis	0.000749	0.0212	CbGpPWpGaD
Aprepitant—TACR3—G alpha (q) signalling events—TAC1—allergic rhinitis	0.000623	0.0176	CbGpPWpGaD
Aprepitant—TACR3—Peptide ligand-binding receptors—TAC1—allergic rhinitis	0.000615	0.0174	CbGpPWpGaD
Aprepitant—TACR3—Class A/1 (Rhodopsin-like receptors)—CYSLTR1—allergic rhinitis	0.000588	0.0166	CbGpPWpGaD
Aprepitant—TACR3—GPCR ligand binding—PTGDR2—allergic rhinitis	0.00057	0.0161	CbGpPWpGaD
Aprepitant—TACR3—Class A/1 (Rhodopsin-like receptors)—CCL11—allergic rhinitis	0.000568	0.0161	CbGpPWpGaD
Aprepitant—TACR3—Gastrin-CREB signalling pathway via PKC and MAPK—TAC1—allergic rhinitis	0.000557	0.0158	CbGpPWpGaD
Aprepitant—TACR3—GPCR ligand binding—CYSLTR1—allergic rhinitis	0.000448	0.0127	CbGpPWpGaD
Aprepitant—TACR1—G alpha (q) signalling events—CYSLTR1—allergic rhinitis	0.000433	0.0123	CbGpPWpGaD
Aprepitant—TACR3—GPCR ligand binding—CCL11—allergic rhinitis	0.000432	0.0122	CbGpPWpGaD
Aprepitant—TACR1—Peptide ligand-binding receptors—CCL11—allergic rhinitis	0.000413	0.0117	CbGpPWpGaD
Aprepitant—TACR3—Class A/1 (Rhodopsin-like receptors)—TAC1—allergic rhinitis	0.000412	0.0117	CbGpPWpGaD
Aprepitant—TACR1—Gastrin-CREB signalling pathway via PKC and MAPK—CYSLTR1—allergic rhinitis	0.000388	0.011	CbGpPWpGaD
Aprepitant—TACR1—SIDS Susceptibility Pathways—IL13—allergic rhinitis	0.000382	0.0108	CbGpPWpGaD
Aprepitant—TACR1—Class A/1 (Rhodopsin-like receptors)—PTGDR2—allergic rhinitis	0.000366	0.0104	CbGpPWpGaD
Aprepitant—TACR1—SIDS Susceptibility Pathways—TAC1—allergic rhinitis	0.000352	0.00995	CbGpPWpGaD
Aprepitant—TACR3—GPCR downstream signaling—PTGDR2—allergic rhinitis	0.000322	0.00912	CbGpPWpGaD
Aprepitant—TACR3—GPCR ligand binding—TAC1—allergic rhinitis	0.000314	0.00889	CbGpPWpGaD
Aprepitant—TACR1—G alpha (q) signalling events—TAC1—allergic rhinitis	0.000304	0.00861	CbGpPWpGaD
Aprepitant—TACR1—Peptide ligand-binding receptors—TAC1—allergic rhinitis	0.0003	0.0085	CbGpPWpGaD
Aprepitant—TACR3—Signaling by GPCR—PTGDR2—allergic rhinitis	0.000293	0.00828	CbGpPWpGaD
Aprepitant—TACR1—Spinal Cord Injury—IL4—allergic rhinitis	0.000291	0.00823	CbGpPWpGaD
Aprepitant—TACR1—Class A/1 (Rhodopsin-like receptors)—CYSLTR1—allergic rhinitis	0.000287	0.00812	CbGpPWpGaD
Aprepitant—TACR1—GPCR ligand binding—PTGDR2—allergic rhinitis	0.000279	0.00788	CbGpPWpGaD
Aprepitant—TACR1—Class A/1 (Rhodopsin-like receptors)—CCL11—allergic rhinitis	0.000277	0.00785	CbGpPWpGaD
Aprepitant—TACR1—Gastrin-CREB signalling pathway via PKC and MAPK—TAC1—allergic rhinitis	0.000272	0.0077	CbGpPWpGaD
Aprepitant—TACR3—GPCR downstream signaling—CYSLTR1—allergic rhinitis	0.000253	0.00716	CbGpPWpGaD
Aprepitant—TACR1—SIDS Susceptibility Pathways—IL10—allergic rhinitis	0.000239	0.00676	CbGpPWpGaD
Aprepitant—TACR1—Spinal Cord Injury—ICAM1—allergic rhinitis	0.000231	0.00653	CbGpPWpGaD
Aprepitant—TACR3—Signaling by GPCR—CYSLTR1—allergic rhinitis	0.00023	0.0065	CbGpPWpGaD
Aprepitant—TACR3—Signaling by GPCR—CCL11—allergic rhinitis	0.000222	0.00628	CbGpPWpGaD
Aprepitant—TACR1—GPCR ligand binding—CYSLTR1—allergic rhinitis	0.000219	0.00619	CbGpPWpGaD
Aprepitant—TACR1—GPCR ligand binding—CCL11—allergic rhinitis	0.000211	0.00597	CbGpPWpGaD
Aprepitant—TACR1—Class A/1 (Rhodopsin-like receptors)—TAC1—allergic rhinitis	0.000201	0.0057	CbGpPWpGaD
Aprepitant—TACR3—GPCR downstream signaling—TAC1—allergic rhinitis	0.000177	0.00502	CbGpPWpGaD
Aprepitant—TACR3—Signaling Pathways—PTGDR2—allergic rhinitis	0.000173	0.00489	CbGpPWpGaD
Aprepitant—TACR3—GPCR downstream signaling—IL5—allergic rhinitis	0.000165	0.00467	CbGpPWpGaD
Aprepitant—TACR3—Signaling by GPCR—TAC1—allergic rhinitis	0.000161	0.00456	CbGpPWpGaD
Aprepitant—TACR1—GPCR downstream signaling—PTGDR2—allergic rhinitis	0.000157	0.00445	CbGpPWpGaD
Aprepitant—TACR1—GPCR ligand binding—TAC1—allergic rhinitis	0.000153	0.00434	CbGpPWpGaD
Aprepitant—TACR3—Signaling by GPCR—IL5—allergic rhinitis	0.00015	0.00424	CbGpPWpGaD
Aprepitant—TACR1—Signaling by GPCR—PTGDR2—allergic rhinitis	0.000143	0.00405	CbGpPWpGaD
Aprepitant—TACR3—Signaling Pathways—CYSLTR1—allergic rhinitis	0.000136	0.00384	CbGpPWpGaD
Aprepitant—TACR3—Signaling Pathways—CCL11—allergic rhinitis	0.000131	0.00371	CbGpPWpGaD
Aprepitant—TACR1—GPCR downstream signaling—CYSLTR1—allergic rhinitis	0.000124	0.0035	CbGpPWpGaD
Aprepitant—TACR1—Spinal Cord Injury—TGFB1—allergic rhinitis	0.000122	0.00345	CbGpPWpGaD
Aprepitant—TACR1—SIDS Susceptibility Pathways—NFKB1—allergic rhinitis	0.000117	0.00331	CbGpPWpGaD
Aprepitant—TACR1—Signaling by GPCR—CYSLTR1—allergic rhinitis	0.000112	0.00317	CbGpPWpGaD
Aprepitant—TACR1—Signaling by GPCR—CCL11—allergic rhinitis	0.000108	0.00307	CbGpPWpGaD
Aprepitant—TACR3—Signaling Pathways—TAC1—allergic rhinitis	9.52e-05	0.00269	CbGpPWpGaD
Aprepitant—CYP2C19—Melatonin metabolism and effects—NFKB1—allergic rhinitis	9.01e-05	0.00255	CbGpPWpGaD
Aprepitant—TACR3—Signaling Pathways—IL5—allergic rhinitis	8.85e-05	0.00251	CbGpPWpGaD
Aprepitant—TACR1—GPCR downstream signaling—TAC1—allergic rhinitis	8.67e-05	0.00245	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—PTGDR2—allergic rhinitis	8.44e-05	0.00239	CbGpPWpGaD
Aprepitant—TACR1—GPCR downstream signaling—IL5—allergic rhinitis	8.06e-05	0.00228	CbGpPWpGaD
Aprepitant—TACR1—Signaling by GPCR—TAC1—allergic rhinitis	7.87e-05	0.00223	CbGpPWpGaD
Aprepitant—TACR1—Signaling by GPCR—IL5—allergic rhinitis	7.32e-05	0.00207	CbGpPWpGaD
Aprepitant—CYP1A2—Melatonin metabolism and effects—NFKB1—allergic rhinitis	7.02e-05	0.00199	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—CYSLTR1—allergic rhinitis	6.63e-05	0.00188	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—CCL11—allergic rhinitis	6.4e-05	0.00181	CbGpPWpGaD
Aprepitant—TACR3—Signaling Pathways—SMAD3—allergic rhinitis	6.23e-05	0.00176	CbGpPWpGaD
Aprepitant—Hallucination—Dexamethasone—allergic rhinitis	6.14e-05	0.000536	CcSEcCtD
Aprepitant—Immune system disorder—Methylprednisolone—allergic rhinitis	6.13e-05	0.000535	CcSEcCtD
Aprepitant—Mediastinal disorder—Methylprednisolone—allergic rhinitis	6.12e-05	0.000534	CcSEcCtD
Aprepitant—Vomiting—Montelukast—allergic rhinitis	6.05e-05	0.000528	CcSEcCtD
Aprepitant—Rash—Montelukast—allergic rhinitis	6e-05	0.000523	CcSEcCtD
Aprepitant—Dermatitis—Montelukast—allergic rhinitis	5.99e-05	0.000523	CcSEcCtD
Aprepitant—Ill-defined disorder—Prednisolone—allergic rhinitis	5.98e-05	0.000522	CcSEcCtD
Aprepitant—Headache—Montelukast—allergic rhinitis	5.96e-05	0.00052	CcSEcCtD
Aprepitant—Mental disorder—Methylprednisolone—allergic rhinitis	5.95e-05	0.000519	CcSEcCtD
Aprepitant—Erythema—Triamcinolone—allergic rhinitis	5.92e-05	0.000517	CcSEcCtD
Aprepitant—Malnutrition—Methylprednisolone—allergic rhinitis	5.91e-05	0.000516	CcSEcCtD
Aprepitant—Erythema—Methylprednisolone—allergic rhinitis	5.91e-05	0.000516	CcSEcCtD
Aprepitant—Angioedema—Prednisolone—allergic rhinitis	5.89e-05	0.000514	CcSEcCtD
Aprepitant—Ill-defined disorder—Hydrocortisone—allergic rhinitis	5.84e-05	0.00051	CcSEcCtD
Aprepitant—Malaise—Prednisolone—allergic rhinitis	5.81e-05	0.000507	CcSEcCtD
Aprepitant—Dysgeusia—Triamcinolone—allergic rhinitis	5.8e-05	0.000506	CcSEcCtD
Aprepitant—Syncope—Prednisolone—allergic rhinitis	5.78e-05	0.000504	CcSEcCtD
Aprepitant—Eye disorder—Betamethasone—allergic rhinitis	5.77e-05	0.000504	CcSEcCtD
Aprepitant—Eye disorder—Dexamethasone—allergic rhinitis	5.77e-05	0.000504	CcSEcCtD
Aprepitant—Angioedema—Hydrocortisone—allergic rhinitis	5.75e-05	0.000502	CcSEcCtD
Aprepitant—Back pain—Triamcinolone—allergic rhinitis	5.73e-05	0.0005	CcSEcCtD
Aprepitant—Malaise—Hydrocortisone—allergic rhinitis	5.67e-05	0.000495	CcSEcCtD
Aprepitant—Loss of consciousness—Prednisolone—allergic rhinitis	5.66e-05	0.000494	CcSEcCtD
Aprepitant—Nausea—Montelukast—allergic rhinitis	5.65e-05	0.000493	CcSEcCtD
Aprepitant—Syncope—Hydrocortisone—allergic rhinitis	5.64e-05	0.000493	CcSEcCtD
Aprepitant—Angiopathy—Dexamethasone—allergic rhinitis	5.6e-05	0.000489	CcSEcCtD
Aprepitant—Angiopathy—Betamethasone—allergic rhinitis	5.6e-05	0.000489	CcSEcCtD
Aprepitant—Convulsion—Prednisolone—allergic rhinitis	5.58e-05	0.000487	CcSEcCtD
Aprepitant—Hypertension—Prednisolone—allergic rhinitis	5.56e-05	0.000486	CcSEcCtD
Aprepitant—Loss of consciousness—Hydrocortisone—allergic rhinitis	5.53e-05	0.000483	CcSEcCtD
Aprepitant—Ill-defined disorder—Triamcinolone—allergic rhinitis	5.5e-05	0.00048	CcSEcCtD
Aprepitant—Ill-defined disorder—Methylprednisolone—allergic rhinitis	5.49e-05	0.000479	CcSEcCtD
Aprepitant—Alopecia—Betamethasone—allergic rhinitis	5.46e-05	0.000476	CcSEcCtD
Aprepitant—Alopecia—Dexamethasone—allergic rhinitis	5.46e-05	0.000476	CcSEcCtD
Aprepitant—Convulsion—Hydrocortisone—allergic rhinitis	5.45e-05	0.000476	CcSEcCtD
Aprepitant—Hypertension—Hydrocortisone—allergic rhinitis	5.43e-05	0.000474	CcSEcCtD
Aprepitant—Discomfort—Prednisolone—allergic rhinitis	5.42e-05	0.000473	CcSEcCtD
Aprepitant—Angioedema—Triamcinolone—allergic rhinitis	5.41e-05	0.000473	CcSEcCtD
Aprepitant—Angioedema—Methylprednisolone—allergic rhinitis	5.4e-05	0.000471	CcSEcCtD
Aprepitant—Erythema—Betamethasone—allergic rhinitis	5.38e-05	0.000469	CcSEcCtD
Aprepitant—Erythema—Dexamethasone—allergic rhinitis	5.38e-05	0.000469	CcSEcCtD
Aprepitant—Myalgia—Hydrocortisone—allergic rhinitis	5.36e-05	0.000468	CcSEcCtD
Aprepitant—Malaise—Triamcinolone—allergic rhinitis	5.34e-05	0.000466	CcSEcCtD
Aprepitant—Anxiety—Hydrocortisone—allergic rhinitis	5.34e-05	0.000466	CcSEcCtD
Aprepitant—Malaise—Methylprednisolone—allergic rhinitis	5.33e-05	0.000465	CcSEcCtD
Aprepitant—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—allergic rhinitis	5.32e-05	0.000464	CcSEcCtD
Aprepitant—Syncope—Triamcinolone—allergic rhinitis	5.31e-05	0.000464	CcSEcCtD
Aprepitant—Syncope—Methylprednisolone—allergic rhinitis	5.3e-05	0.000463	CcSEcCtD
Aprepitant—Discomfort—Hydrocortisone—allergic rhinitis	5.29e-05	0.000462	CcSEcCtD
Aprepitant—Oedema—Prednisolone—allergic rhinitis	5.26e-05	0.000459	CcSEcCtD
Aprepitant—Anaphylactic shock—Prednisolone—allergic rhinitis	5.26e-05	0.000459	CcSEcCtD
Aprepitant—Loss of consciousness—Triamcinolone—allergic rhinitis	5.21e-05	0.000455	CcSEcCtD
Aprepitant—Loss of consciousness—Methylprednisolone—allergic rhinitis	5.2e-05	0.000454	CcSEcCtD
Aprepitant—Shock—Prednisolone—allergic rhinitis	5.17e-05	0.000452	CcSEcCtD
Aprepitant—Cough—Triamcinolone—allergic rhinitis	5.17e-05	0.000451	CcSEcCtD
Aprepitant—Oedema—Hydrocortisone—allergic rhinitis	5.14e-05	0.000448	CcSEcCtD
Aprepitant—Anaphylactic shock—Hydrocortisone—allergic rhinitis	5.14e-05	0.000448	CcSEcCtD
Aprepitant—Convulsion—Triamcinolone—allergic rhinitis	5.13e-05	0.000448	CcSEcCtD
Aprepitant—Tachycardia—Prednisolone—allergic rhinitis	5.13e-05	0.000448	CcSEcCtD
Aprepitant—Convulsion—Methylprednisolone—allergic rhinitis	5.12e-05	0.000447	CcSEcCtD
Aprepitant—Hypertension—Triamcinolone—allergic rhinitis	5.12e-05	0.000446	CcSEcCtD
Aprepitant—Hypertension—Methylprednisolone—allergic rhinitis	5.1e-05	0.000445	CcSEcCtD
Aprepitant—Infection—Hydrocortisone—allergic rhinitis	5.1e-05	0.000445	CcSEcCtD
Aprepitant—Hyperhidrosis—Prednisolone—allergic rhinitis	5.08e-05	0.000444	CcSEcCtD
Aprepitant—Shock—Hydrocortisone—allergic rhinitis	5.05e-05	0.000441	CcSEcCtD
Aprepitant—Myalgia—Triamcinolone—allergic rhinitis	5.04e-05	0.00044	CcSEcCtD
Aprepitant—Nervous system disorder—Hydrocortisone—allergic rhinitis	5.04e-05	0.00044	CcSEcCtD
Aprepitant—Myalgia—Methylprednisolone—allergic rhinitis	5.03e-05	0.000439	CcSEcCtD
Aprepitant—Arthralgia—Methylprednisolone—allergic rhinitis	5.03e-05	0.000439	CcSEcCtD
Aprepitant—Anxiety—Methylprednisolone—allergic rhinitis	5.02e-05	0.000438	CcSEcCtD
Aprepitant—Tachycardia—Hydrocortisone—allergic rhinitis	5.01e-05	0.000437	CcSEcCtD
Aprepitant—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—allergic rhinitis	5e-05	0.000436	CcSEcCtD
Aprepitant—Skin disorder—Hydrocortisone—allergic rhinitis	4.99e-05	0.000435	CcSEcCtD
Aprepitant—Ill-defined disorder—Dexamethasone—allergic rhinitis	4.99e-05	0.000435	CcSEcCtD
Aprepitant—Ill-defined disorder—Betamethasone—allergic rhinitis	4.99e-05	0.000435	CcSEcCtD
Aprepitant—Discomfort—Triamcinolone—allergic rhinitis	4.98e-05	0.000435	CcSEcCtD
Aprepitant—Discomfort—Methylprednisolone—allergic rhinitis	4.97e-05	0.000434	CcSEcCtD
Aprepitant—Hyperhidrosis—Hydrocortisone—allergic rhinitis	4.96e-05	0.000433	CcSEcCtD
Aprepitant—Dry mouth—Triamcinolone—allergic rhinitis	4.93e-05	0.000431	CcSEcCtD
Aprepitant—Angioedema—Dexamethasone—allergic rhinitis	4.91e-05	0.000429	CcSEcCtD
Aprepitant—Angioedema—Betamethasone—allergic rhinitis	4.91e-05	0.000429	CcSEcCtD
Aprepitant—Anorexia—Hydrocortisone—allergic rhinitis	4.9e-05	0.000427	CcSEcCtD
Aprepitant—Confusional state—Methylprednisolone—allergic rhinitis	4.86e-05	0.000425	CcSEcCtD
Aprepitant—CYP1A2—Aryl Hydrocarbon Receptor—NFKB1—allergic rhinitis	4.86e-05	0.00137	CbGpPWpGaD
Aprepitant—Malaise—Betamethasone—allergic rhinitis	4.85e-05	0.000423	CcSEcCtD
Aprepitant—Malaise—Dexamethasone—allergic rhinitis	4.85e-05	0.000423	CcSEcCtD
Aprepitant—Anaphylactic shock—Triamcinolone—allergic rhinitis	4.84e-05	0.000422	CcSEcCtD
Aprepitant—Oedema—Triamcinolone—allergic rhinitis	4.84e-05	0.000422	CcSEcCtD
Aprepitant—Anaphylactic shock—Methylprednisolone—allergic rhinitis	4.82e-05	0.000421	CcSEcCtD
Aprepitant—Syncope—Betamethasone—allergic rhinitis	4.82e-05	0.000421	CcSEcCtD
Aprepitant—Syncope—Dexamethasone—allergic rhinitis	4.82e-05	0.000421	CcSEcCtD
Aprepitant—Infection—Triamcinolone—allergic rhinitis	4.8e-05	0.000419	CcSEcCtD
Aprepitant—Hypotension—Hydrocortisone—allergic rhinitis	4.8e-05	0.000419	CcSEcCtD
Aprepitant—Infection—Methylprednisolone—allergic rhinitis	4.79e-05	0.000418	CcSEcCtD
Aprepitant—Shock—Triamcinolone—allergic rhinitis	4.76e-05	0.000415	CcSEcCtD
Aprepitant—Insomnia—Prednisolone—allergic rhinitis	4.76e-05	0.000415	CcSEcCtD
Aprepitant—Shock—Methylprednisolone—allergic rhinitis	4.75e-05	0.000414	CcSEcCtD
Aprepitant—Nervous system disorder—Methylprednisolone—allergic rhinitis	4.73e-05	0.000413	CcSEcCtD
Aprepitant—Loss of consciousness—Betamethasone—allergic rhinitis	4.73e-05	0.000412	CcSEcCtD
Aprepitant—Loss of consciousness—Dexamethasone—allergic rhinitis	4.73e-05	0.000412	CcSEcCtD
Aprepitant—Paraesthesia—Prednisolone—allergic rhinitis	4.72e-05	0.000412	CcSEcCtD
Aprepitant—Tachycardia—Triamcinolone—allergic rhinitis	4.72e-05	0.000412	CcSEcCtD
Aprepitant—Tachycardia—Methylprednisolone—allergic rhinitis	4.71e-05	0.000411	CcSEcCtD
Aprepitant—Skin disorder—Methylprednisolone—allergic rhinitis	4.69e-05	0.000409	CcSEcCtD
Aprepitant—Musculoskeletal discomfort—Hydrocortisone—allergic rhinitis	4.68e-05	0.000408	CcSEcCtD
Aprepitant—Hyperhidrosis—Triamcinolone—allergic rhinitis	4.67e-05	0.000408	CcSEcCtD
Aprepitant—Hyperhidrosis—Methylprednisolone—allergic rhinitis	4.66e-05	0.000407	CcSEcCtD
Aprepitant—Convulsion—Betamethasone—allergic rhinitis	4.66e-05	0.000407	CcSEcCtD
Aprepitant—Convulsion—Dexamethasone—allergic rhinitis	4.66e-05	0.000407	CcSEcCtD
Aprepitant—TACR1—Signaling Pathways—TAC1—allergic rhinitis	4.65e-05	0.00132	CbGpPWpGaD
Aprepitant—Insomnia—Hydrocortisone—allergic rhinitis	4.64e-05	0.000405	CcSEcCtD
Aprepitant—Hypertension—Dexamethasone—allergic rhinitis	4.64e-05	0.000405	CcSEcCtD
Aprepitant—Hypertension—Betamethasone—allergic rhinitis	4.64e-05	0.000405	CcSEcCtD
Aprepitant—Paraesthesia—Hydrocortisone—allergic rhinitis	4.61e-05	0.000402	CcSEcCtD
Aprepitant—Myalgia—Dexamethasone—allergic rhinitis	4.58e-05	0.000399	CcSEcCtD
Aprepitant—Myalgia—Betamethasone—allergic rhinitis	4.58e-05	0.000399	CcSEcCtD
Aprepitant—Anxiety—Betamethasone—allergic rhinitis	4.56e-05	0.000398	CcSEcCtD
Aprepitant—Anxiety—Dexamethasone—allergic rhinitis	4.56e-05	0.000398	CcSEcCtD
Aprepitant—Discomfort—Dexamethasone—allergic rhinitis	4.52e-05	0.000395	CcSEcCtD
Aprepitant—Discomfort—Betamethasone—allergic rhinitis	4.52e-05	0.000395	CcSEcCtD
Aprepitant—Dyspepsia—Hydrocortisone—allergic rhinitis	4.52e-05	0.000395	CcSEcCtD
Aprepitant—Hypotension—Methylprednisolone—allergic rhinitis	4.51e-05	0.000394	CcSEcCtD
Aprepitant—Pain—Prednisolone—allergic rhinitis	4.5e-05	0.000392	CcSEcCtD
Aprepitant—Decreased appetite—Hydrocortisone—allergic rhinitis	4.46e-05	0.00039	CcSEcCtD
Aprepitant—Gastrointestinal disorder—Hydrocortisone—allergic rhinitis	4.43e-05	0.000387	CcSEcCtD
Aprepitant—Fatigue—Hydrocortisone—allergic rhinitis	4.43e-05	0.000386	CcSEcCtD
Aprepitant—Musculoskeletal discomfort—Triamcinolone—allergic rhinitis	4.41e-05	0.000385	CcSEcCtD
Aprepitant—Musculoskeletal discomfort—Methylprednisolone—allergic rhinitis	4.4e-05	0.000384	CcSEcCtD
Aprepitant—Pain—Hydrocortisone—allergic rhinitis	4.39e-05	0.000383	CcSEcCtD
Aprepitant—Anaphylactic shock—Betamethasone—allergic rhinitis	4.39e-05	0.000383	CcSEcCtD
Aprepitant—Oedema—Betamethasone—allergic rhinitis	4.39e-05	0.000383	CcSEcCtD
Aprepitant—Anaphylactic shock—Dexamethasone—allergic rhinitis	4.39e-05	0.000383	CcSEcCtD
Aprepitant—Oedema—Dexamethasone—allergic rhinitis	4.39e-05	0.000383	CcSEcCtD
Aprepitant—Insomnia—Triamcinolone—allergic rhinitis	4.37e-05	0.000382	CcSEcCtD
Aprepitant—Insomnia—Methylprednisolone—allergic rhinitis	4.36e-05	0.000381	CcSEcCtD
Aprepitant—Infection—Betamethasone—allergic rhinitis	4.36e-05	0.00038	CcSEcCtD
Aprepitant—Infection—Dexamethasone—allergic rhinitis	4.36e-05	0.00038	CcSEcCtD
Aprepitant—Paraesthesia—Triamcinolone—allergic rhinitis	4.34e-05	0.000379	CcSEcCtD
Aprepitant—Feeling abnormal—Prednisolone—allergic rhinitis	4.33e-05	0.000378	CcSEcCtD
Aprepitant—Paraesthesia—Methylprednisolone—allergic rhinitis	4.33e-05	0.000378	CcSEcCtD
Aprepitant—TACR1—Signaling Pathways—IL5—allergic rhinitis	4.32e-05	0.00122	CbGpPWpGaD
Aprepitant—Shock—Dexamethasone—allergic rhinitis	4.32e-05	0.000377	CcSEcCtD
Aprepitant—Shock—Betamethasone—allergic rhinitis	4.32e-05	0.000377	CcSEcCtD
Aprepitant—Dyspnoea—Triamcinolone—allergic rhinitis	4.31e-05	0.000376	CcSEcCtD
Aprepitant—Nervous system disorder—Dexamethasone—allergic rhinitis	4.3e-05	0.000376	CcSEcCtD
Aprepitant—Nervous system disorder—Betamethasone—allergic rhinitis	4.3e-05	0.000376	CcSEcCtD
Aprepitant—Thrombocytopenia—Betamethasone—allergic rhinitis	4.3e-05	0.000375	CcSEcCtD
Aprepitant—Thrombocytopenia—Dexamethasone—allergic rhinitis	4.3e-05	0.000375	CcSEcCtD
Aprepitant—Tachycardia—Betamethasone—allergic rhinitis	4.28e-05	0.000374	CcSEcCtD
Aprepitant—Tachycardia—Dexamethasone—allergic rhinitis	4.28e-05	0.000374	CcSEcCtD
Aprepitant—Dyspepsia—Triamcinolone—allergic rhinitis	4.26e-05	0.000372	CcSEcCtD
Aprepitant—Dyspepsia—Methylprednisolone—allergic rhinitis	4.25e-05	0.000371	CcSEcCtD
Aprepitant—Hyperhidrosis—Betamethasone—allergic rhinitis	4.24e-05	0.00037	CcSEcCtD
Aprepitant—Hyperhidrosis—Dexamethasone—allergic rhinitis	4.24e-05	0.00037	CcSEcCtD
Aprepitant—Feeling abnormal—Hydrocortisone—allergic rhinitis	4.23e-05	0.000369	CcSEcCtD
Aprepitant—Gastrointestinal pain—Hydrocortisone—allergic rhinitis	4.2e-05	0.000367	CcSEcCtD
Aprepitant—Anorexia—Betamethasone—allergic rhinitis	4.18e-05	0.000365	CcSEcCtD
Aprepitant—Anorexia—Dexamethasone—allergic rhinitis	4.18e-05	0.000365	CcSEcCtD
Aprepitant—Urticaria—Prednisolone—allergic rhinitis	4.18e-05	0.000365	CcSEcCtD
Aprepitant—Fatigue—Triamcinolone—allergic rhinitis	4.17e-05	0.000364	CcSEcCtD
Aprepitant—Fatigue—Methylprednisolone—allergic rhinitis	4.16e-05	0.000363	CcSEcCtD
Aprepitant—Pain—Triamcinolone—allergic rhinitis	4.14e-05	0.000361	CcSEcCtD
Aprepitant—Hypotension—Dexamethasone—allergic rhinitis	4.1e-05	0.000358	CcSEcCtD
Aprepitant—Hypotension—Betamethasone—allergic rhinitis	4.1e-05	0.000358	CcSEcCtD
Aprepitant—Urticaria—Hydrocortisone—allergic rhinitis	4.08e-05	0.000356	CcSEcCtD
Aprepitant—Abdominal pain—Hydrocortisone—allergic rhinitis	4.06e-05	0.000354	CcSEcCtD
Aprepitant—Body temperature increased—Hydrocortisone—allergic rhinitis	4.06e-05	0.000354	CcSEcCtD
Aprepitant—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—allergic rhinitis	4.04e-05	0.00114	CbGpPWpGaD
Aprepitant—Musculoskeletal discomfort—Dexamethasone—allergic rhinitis	4e-05	0.000349	CcSEcCtD
Aprepitant—Musculoskeletal discomfort—Betamethasone—allergic rhinitis	4e-05	0.000349	CcSEcCtD
Aprepitant—Feeling abnormal—Triamcinolone—allergic rhinitis	3.98e-05	0.000348	CcSEcCtD
Aprepitant—Feeling abnormal—Methylprednisolone—allergic rhinitis	3.98e-05	0.000347	CcSEcCtD
Aprepitant—Insomnia—Dexamethasone—allergic rhinitis	3.97e-05	0.000346	CcSEcCtD
Aprepitant—Insomnia—Betamethasone—allergic rhinitis	3.97e-05	0.000346	CcSEcCtD
Aprepitant—Gastrointestinal pain—Methylprednisolone—allergic rhinitis	3.95e-05	0.000344	CcSEcCtD
Aprepitant—Paraesthesia—Dexamethasone—allergic rhinitis	3.94e-05	0.000344	CcSEcCtD
Aprepitant—Paraesthesia—Betamethasone—allergic rhinitis	3.94e-05	0.000344	CcSEcCtD
Aprepitant—Hypersensitivity—Prednisolone—allergic rhinitis	3.87e-05	0.000338	CcSEcCtD
Aprepitant—Dyspepsia—Betamethasone—allergic rhinitis	3.86e-05	0.000337	CcSEcCtD
Aprepitant—Dyspepsia—Dexamethasone—allergic rhinitis	3.86e-05	0.000337	CcSEcCtD
Aprepitant—Urticaria—Triamcinolone—allergic rhinitis	3.84e-05	0.000335	CcSEcCtD
Aprepitant—Urticaria—Methylprednisolone—allergic rhinitis	3.83e-05	0.000335	CcSEcCtD
Aprepitant—Body temperature increased—Triamcinolone—allergic rhinitis	3.82e-05	0.000334	CcSEcCtD
Aprepitant—Abdominal pain—Methylprednisolone—allergic rhinitis	3.81e-05	0.000333	CcSEcCtD
Aprepitant—Decreased appetite—Betamethasone—allergic rhinitis	3.81e-05	0.000333	CcSEcCtD
Aprepitant—Decreased appetite—Dexamethasone—allergic rhinitis	3.81e-05	0.000333	CcSEcCtD
Aprepitant—Gastrointestinal disorder—Betamethasone—allergic rhinitis	3.79e-05	0.000331	CcSEcCtD
Aprepitant—Gastrointestinal disorder—Dexamethasone—allergic rhinitis	3.79e-05	0.000331	CcSEcCtD
Aprepitant—Hypersensitivity—Hydrocortisone—allergic rhinitis	3.78e-05	0.00033	CcSEcCtD
Aprepitant—Fatigue—Betamethasone—allergic rhinitis	3.78e-05	0.00033	CcSEcCtD
Aprepitant—Fatigue—Dexamethasone—allergic rhinitis	3.78e-05	0.00033	CcSEcCtD
Aprepitant—Pain—Dexamethasone—allergic rhinitis	3.75e-05	0.000327	CcSEcCtD
Aprepitant—Pain—Betamethasone—allergic rhinitis	3.75e-05	0.000327	CcSEcCtD
Aprepitant—Asthenia—Hydrocortisone—allergic rhinitis	3.68e-05	0.000322	CcSEcCtD
Aprepitant—Pruritus—Hydrocortisone—allergic rhinitis	3.63e-05	0.000317	CcSEcCtD
Aprepitant—Feeling abnormal—Dexamethasone—allergic rhinitis	3.62e-05	0.000316	CcSEcCtD
Aprepitant—Feeling abnormal—Betamethasone—allergic rhinitis	3.62e-05	0.000316	CcSEcCtD
Aprepitant—Gastrointestinal pain—Dexamethasone—allergic rhinitis	3.59e-05	0.000313	CcSEcCtD
Aprepitant—Gastrointestinal pain—Betamethasone—allergic rhinitis	3.59e-05	0.000313	CcSEcCtD
Aprepitant—Hypersensitivity—Triamcinolone—allergic rhinitis	3.56e-05	0.000311	CcSEcCtD
Aprepitant—Hypersensitivity—Methylprednisolone—allergic rhinitis	3.55e-05	0.00031	CcSEcCtD
Aprepitant—Diarrhoea—Hydrocortisone—allergic rhinitis	3.51e-05	0.000307	CcSEcCtD
Aprepitant—Urticaria—Betamethasone—allergic rhinitis	3.49e-05	0.000304	CcSEcCtD
Aprepitant—Urticaria—Dexamethasone—allergic rhinitis	3.49e-05	0.000304	CcSEcCtD
Aprepitant—Dizziness—Prednisolone—allergic rhinitis	3.48e-05	0.000303	CcSEcCtD
Aprepitant—Asthenia—Triamcinolone—allergic rhinitis	3.47e-05	0.000303	CcSEcCtD
Aprepitant—Body temperature increased—Dexamethasone—allergic rhinitis	3.47e-05	0.000303	CcSEcCtD
Aprepitant—Body temperature increased—Betamethasone—allergic rhinitis	3.47e-05	0.000303	CcSEcCtD
Aprepitant—Abdominal pain—Betamethasone—allergic rhinitis	3.47e-05	0.000303	CcSEcCtD
Aprepitant—Abdominal pain—Dexamethasone—allergic rhinitis	3.47e-05	0.000303	CcSEcCtD
Aprepitant—Asthenia—Methylprednisolone—allergic rhinitis	3.46e-05	0.000302	CcSEcCtD
Aprepitant—Pruritus—Triamcinolone—allergic rhinitis	3.42e-05	0.000299	CcSEcCtD
Aprepitant—Pruritus—Methylprednisolone—allergic rhinitis	3.41e-05	0.000298	CcSEcCtD
Aprepitant—Dizziness—Hydrocortisone—allergic rhinitis	3.4e-05	0.000296	CcSEcCtD
Aprepitant—Rash—Prednisolone—allergic rhinitis	3.32e-05	0.000289	CcSEcCtD
Aprepitant—Dermatitis—Prednisolone—allergic rhinitis	3.31e-05	0.000289	CcSEcCtD
Aprepitant—Diarrhoea—Methylprednisolone—allergic rhinitis	3.3e-05	0.000288	CcSEcCtD
Aprepitant—Headache—Prednisolone—allergic rhinitis	3.29e-05	0.000288	CcSEcCtD
Aprepitant—Vomiting—Hydrocortisone—allergic rhinitis	3.27e-05	0.000285	CcSEcCtD
Aprepitant—Rash—Hydrocortisone—allergic rhinitis	3.24e-05	0.000283	CcSEcCtD
Aprepitant—Dermatitis—Hydrocortisone—allergic rhinitis	3.23e-05	0.000282	CcSEcCtD
Aprepitant—Headache—Hydrocortisone—allergic rhinitis	3.22e-05	0.000281	CcSEcCtD
Aprepitant—Dizziness—Triamcinolone—allergic rhinitis	3.2e-05	0.000279	CcSEcCtD
Aprepitant—Dizziness—Methylprednisolone—allergic rhinitis	3.19e-05	0.000278	CcSEcCtD
Aprepitant—TACR3—Signaling Pathways—NFKB1—allergic rhinitis	3.17e-05	0.000896	CbGpPWpGaD
Aprepitant—Asthenia—Dexamethasone—allergic rhinitis	3.15e-05	0.000275	CcSEcCtD
Aprepitant—Asthenia—Betamethasone—allergic rhinitis	3.15e-05	0.000275	CcSEcCtD
Aprepitant—Nausea—Prednisolone—allergic rhinitis	3.12e-05	0.000273	CcSEcCtD
Aprepitant—Pruritus—Betamethasone—allergic rhinitis	3.1e-05	0.000271	CcSEcCtD
Aprepitant—Pruritus—Dexamethasone—allergic rhinitis	3.1e-05	0.000271	CcSEcCtD
Aprepitant—Vomiting—Triamcinolone—allergic rhinitis	3.07e-05	0.000268	CcSEcCtD
Aprepitant—Vomiting—Methylprednisolone—allergic rhinitis	3.07e-05	0.000268	CcSEcCtD
Aprepitant—Nausea—Hydrocortisone—allergic rhinitis	3.05e-05	0.000266	CcSEcCtD
Aprepitant—Rash—Triamcinolone—allergic rhinitis	3.05e-05	0.000266	CcSEcCtD
Aprepitant—Dermatitis—Triamcinolone—allergic rhinitis	3.05e-05	0.000266	CcSEcCtD
Aprepitant—TACR1—Signaling Pathways—SMAD3—allergic rhinitis	3.04e-05	0.000861	CbGpPWpGaD
Aprepitant—Rash—Methylprednisolone—allergic rhinitis	3.04e-05	0.000266	CcSEcCtD
Aprepitant—Dermatitis—Methylprednisolone—allergic rhinitis	3.04e-05	0.000265	CcSEcCtD
Aprepitant—Headache—Triamcinolone—allergic rhinitis	3.03e-05	0.000264	CcSEcCtD
Aprepitant—Headache—Methylprednisolone—allergic rhinitis	3.02e-05	0.000264	CcSEcCtD
Aprepitant—Diarrhoea—Dexamethasone—allergic rhinitis	3e-05	0.000262	CcSEcCtD
Aprepitant—Diarrhoea—Betamethasone—allergic rhinitis	3e-05	0.000262	CcSEcCtD
Aprepitant—Dizziness—Betamethasone—allergic rhinitis	2.9e-05	0.000253	CcSEcCtD
Aprepitant—Dizziness—Dexamethasone—allergic rhinitis	2.9e-05	0.000253	CcSEcCtD
Aprepitant—Nausea—Triamcinolone—allergic rhinitis	2.87e-05	0.000251	CcSEcCtD
Aprepitant—Nausea—Methylprednisolone—allergic rhinitis	2.87e-05	0.00025	CcSEcCtD
Aprepitant—Vomiting—Dexamethasone—allergic rhinitis	2.79e-05	0.000243	CcSEcCtD
Aprepitant—Vomiting—Betamethasone—allergic rhinitis	2.79e-05	0.000243	CcSEcCtD
Aprepitant—Rash—Dexamethasone—allergic rhinitis	2.77e-05	0.000241	CcSEcCtD
Aprepitant—Rash—Betamethasone—allergic rhinitis	2.77e-05	0.000241	CcSEcCtD
Aprepitant—Dermatitis—Betamethasone—allergic rhinitis	2.76e-05	0.000241	CcSEcCtD
Aprepitant—Dermatitis—Dexamethasone—allergic rhinitis	2.76e-05	0.000241	CcSEcCtD
Aprepitant—Headache—Betamethasone—allergic rhinitis	2.75e-05	0.00024	CcSEcCtD
Aprepitant—Headache—Dexamethasone—allergic rhinitis	2.75e-05	0.00024	CcSEcCtD
Aprepitant—TACR3—Signaling Pathways—TGFB1—allergic rhinitis	2.64e-05	0.000747	CbGpPWpGaD
Aprepitant—Nausea—Dexamethasone—allergic rhinitis	2.61e-05	0.000227	CcSEcCtD
Aprepitant—Nausea—Betamethasone—allergic rhinitis	2.61e-05	0.000227	CcSEcCtD
Aprepitant—TACR1—Signaling Pathways—NFKB1—allergic rhinitis	1.55e-05	0.000438	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—TGFB1—allergic rhinitis	1.29e-05	0.000365	CbGpPWpGaD
